ExploreWatchlistsPricing
  1. JP-listed companies
  2. Kubota Pharmaceutical Holdings Co., Ltd.
  3. Financials
  4. Pretax margin (%)

Kubota Pharmaceutical Holdings Co., Ltd. (4596)

Market cap
¥11.3B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Dec 31, 2025-3,169.7-35.34%
Dec 31, 2024-4,902.2+31.27%
Dec 31, 2023-3,734.6-84.71%
Dec 31, 2022-24,423.4+1518.78%
Dec 31, 2021-1,508.8-76.61%
Dec 31, 2020-6,450.6+427.60%
Dec 31, 2019-1,222.6+4.34%
Dec 31, 2018-1,171.8+43.69%
Dec 31, 2017-815.5+79.53%
Dec 31, 2016-454.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat